Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome
Crossref DOI link: https://doi.org/10.1007/s00216-015-9150-z
Published Online: 2015-11-12
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mutemberezi, Valentin
Masquelier, Julien
Guillemot-Legris, Owein
Muccioli, Giulio G.
Funding for this research was provided by:
FRS-FNRS (CC 1.5.034.10, FRFC 2.4555.08, J.0160.13)
Text and Data Mining valid from 2015-11-12